Cargando…

A patient with mexiletine-related psychosis

Mexiletine is a commonly used Class IB (Vaughan William classification) antiarrhythmic drug. We report a case of mexiletine-induced psychosis that was successfully managed by decreasing the dose and using alternative medications for management of ventricular tachycardia.

Detalles Bibliográficos
Autores principales:	Shailesh, Fnu, Singla, Sandeep, Sureddi, Ravi, Deshmukh, Abhishek J, Paydak, Hakan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219764/ https://www.ncbi.nlm.nih.gov/pubmed/22114522 http://dx.doi.org/10.2147/IJGM.S25381

Ejemplares similares

Experience with oral mexiletine in primary erythromelalgia in children
por: Iqbal, Javeed, et al.
Publicado: (2009)

Flecainide associated torsade de pointes: A potential case of reverse use dependence
por: Hayes, Kevin, et al.
Publicado: (2013)

Accessory pathway–mediated cardiomyopathy: Left ventricular systolic dysfunction due to preexcitation
por: Lee, Hong-Seok, et al.
Publicado: (2020)

Mexiletine shortens the QT interval in a pedigree of KCNH2 related long QT syndrome
por: Fujisawa, Taishi, et al.
Publicado: (2020)

A Case of Mexiletine-induced Hypersensitivity Syndrome Presenting as Eosinophilic Pneumonia
por: Lee, Sang-Pyo, et al.
Publicado: (2010)

Mexiletine and False Positive Urine Drug Screen for Amphetamine: A Case Review
por: Sohal, Sumit, et al.
Publicado: (2021)

Mexiletine infusion challenge test for neonatal long QT syndrome with 2:1 atrioventricular block
por: Okuwaki, Hajime, et al.
Publicado: (2019)

Recurrence of complete heart block in pregnancy
por: Young, Daniel, et al.
Publicado: (2021)

Utilization of YouTube as a Tool to Assess Patient Perception Regarding Implanted Cardiac Devices
por: Hayes, Kevin, et al.
Publicado: (2014)

Molecular Modeling of Cardiac Sodium Channel with Mexiletine
por: Zhorov, Boris S.
Publicado: (2022)

A combination of quinidine/mexiletine reduces arrhythmia in dilated cardiomyopathy in two patients with R814W SCN5A mutation
por: Zakrzewska‐Koperska, Joanna, et al.
Publicado: (2020)

Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation
por: Liu, Guizhi, et al.
Publicado: (2017)

A Case of Long QT Syndrome Type 3 Aggravated by Beta-Blockers and Alleviated by Mexiletine: The Role of Epinephrine Provocation Test
por: Park, Junbeom, et al.
Publicado: (2013)

Utilizing the Cool-Down Phenomenon to Differentiate Supraventricular Tachycardias in a Patient with COVID-19 Infection
por: Sawalha, Khalid, et al.
Publicado: (2021)

Theophylline in Treatment of COVID-19 Induced Sinus Bradycardia
por: Sawalha, Khalid, et al.
Publicado: (2021)

Near-zero fluoroscopy implantation of dual-chamber pacemaker in pregnancy using electroanatomic mapping
por: Payne, Jason, et al.
Publicado: (2017)

Inappropriate Sinus Tachycardia Following Viral Illness
por: Sawalha, Khalid, et al.
Publicado: (2021)

Graft-versus-host disease: A rare complication of device implantation
por: Xu, Jack, et al.
Publicado: (2016)

Therapeutic drug monitoring of mexiletine at a large academic medical center
por: Nei, Scott D, et al.
Publicado: (2016)

ST Segment Elevation and Depressions in Supraventricular Tachycardia without Coronary Artery Disease
por: Habash, Fuad, et al.
Publicado: (2018)

Reproducible asystole following vagal nerve stimulator lead replacement: a case report
por: Scott, Hayden, et al.
Publicado: (2022)

Chronic lead malposition diagnosis and management: discussion of two cases and literature review
por: Almomani, Ahmed, et al.
Publicado: (2017)

Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial
por: Yamada, Shinichiro, et al.
Publicado: (2022)

Management of ventricular tachycardia--role of mexiletine : proceedings of a symposium held in Copenhagen, Denmark, 25th-27th May, 1978 /
Publicado: (1978)

Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review
por: van der Ree, Martijn H, et al.
Publicado: (2022)

Case report: Mexiletine suppresses ventricular arrhythmias in Andersen-Tawil syndrome
por: Yang, Jing, et al.
Publicado: (2022)

Designer Gelators for the Crystallization of a Salt Active Pharmaceutical Ingredient—Mexiletine Hydrochloride
por: Andrews, Jessica L., et al.
Publicado: (2022)

Can bupropion unmask psychosis
por: Grover, Sandeep, et al.
Publicado: (2009)

Lemierre syndrome from a neck abscess due to methicillin-resistant Staphylococcus aureus
por: Abhishek, Agarwal, et al.
Publicado: (2013)

Mexiletine Differentially Restores the Trafficking Defects Caused by Two Brugada Syndrome Mutations
por: Moreau, Adrien, et al.
Publicado: (2012)

Mexiletine Treatment for Neonatal LQT3 Syndrome: Case Report and Literature Review
por: Bagkaki, Alena, et al.
Publicado: (2021)

Mexiletine-like cellular electrophysiological effects of GS967 in canine ventricular myocardium
por: Hézső, Tamás, et al.
Publicado: (2021)

Supersensitivity Psychosis and Its Response to Asenapine in a Patient with Delusional Disorder
por: Rajkumar, Ravi Philip
Publicado: (2014)

Characterization of a novel LQT3 variant with a selective efficacy of mexiletine treatment
por: Kim, Hyun-Ji, et al.
Publicado: (2019)

Long-Term Safety and Usefulness of Mexiletine in a Large Cohort of Patients Affected by Non-dystrophic Myotonias
por: Modoni, Anna, et al.
Publicado: (2020)

Interactions of Mexiletine with Novel Antiepileptic Drugs in the Maximal Electroshock Test in Mice: An Isobolographic Analysis
por: Wróblewska, Dorota, et al.
Publicado: (2018)

Acute psychosis as the presenting manifestation of lupus
por: Kumar, Piyush, et al.
Publicado: (2021)

Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3
por: Mazzanti, Andrea, et al.
Publicado: (2016)

The Effect of Sodium Channel Blocker, Mexiletine, on Body Weight in Type 2 Diabetes Patients with Visceral Obesity
por: Ueno, Naohiko
Publicado: (2019)

Bilateral Pleural Effusions due to Pulmonary Amyloidosis as the Presenting Manifestation of Multiple Myeloma
por: Agarwal, Abhishek, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_u2o5a36clpdstgthk0tvc3kseq